This feature is a deep dive into the challenges of defining and treating Difficult-to-Treat Rheumatoid Arthritis (D2T-RA).
Shares of AnaptysBio (NASDAQ:ANAB) climbed ~12% in the premarket on Wednesday after the biotech said its lead asset, rosnilimab, reached the main goals in a mid-stage trial targeted at the autoimmune ...
Dr. Carrie Jose, in her latest Health and Wellness column, provides six natural ways to relieve arthritis pain - without meds ...
2d
Investor's Business Daily on MSNAnaptysBio Whipsaws On Promising Results In Rheumatoid Arthritis TreatmentAnaptysBio stock whipsawed Wednesday despite promising results for its experimental rheumatoid arthritis treatment.
Depression and anxiety among patients with inflammatory arthritis is significantly undertreated, with large proportions not ...
Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...
3d
Everyday Health on MSNUnderstanding Disease Progression in Rheumatoid ArthritisUnderstand RA from early to advanced stages. Explore symptoms, treatments, and lifestyle tips to manage rheumatoid arthritis ...
A positive association was found between osteoarthritis and overactive bladder (OAB), but rheumatoid arthritis and psoriatic ...
Even though there are numerous forms of arthritis therapy available, finding the most potent pain management for knee arthritis can be challenging. There are several types of pain relievers ...
Rheumatoid arthritis (RA) is an inflammatory arthritis characterized by chronic joint inflammation, cartilage degradation, and bone erosion.
Jeffrey Stark, MD, vice president and head of medical immunology at UCB, discusses tailored dosing of bimekizumab-bkzx ...
Arthritis and bursitis are common joint pain causes, but differ in origin and treatment. Arthritis inflames joints due to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results